封面
市場調查報告書
商品編碼
1136941

組織銀行市場:各產品類型,各地區,規模,佔有率,展望,機會分析,2022年~2030年

Tissue Banking Market, by Product, by Tissue Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

市場動態

對移植物的手術需求增加、髖關節置換手術中的骨移植物需求、股骨頭移植物需求以及燒傷患者發病率的增加是推動組織庫市場增長的主要因素。

本調查的主要特徵

  • 本報告提供以2021年為基準年的預測期間(2022-2030 年)之全球組織銀行市場的市場規模和復合年增長率(CAGR %)相關的詳細分析。
  • 並闡明不同部門市場的潛在收入機會,說明該市場具有魅力的投資主張矩陣。
  • 同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
  • 並基於企業亮點,各類型投資組合、主要焦點、財務業績和市場策略等參數,介紹全球組織銀行市場的主要參與者之企業簡介。
  • 藉由該報告提供的洞察,將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
  • 全球組織銀行市場報告配合該行業的各種利益相關者,包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以透過全球組織銀行市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

目錄

第1章 調查目的與前提條件

  • 調查目的
  • 前提條件
  • 簡稱的說明

第2章 市場展望

  • 報告內容
    • 市場定義和範圍
  • 摘要整理
    • 市場概述:各產品
    • 市場概述:組織各類型
    • 市場概述:各地區
  • 連貫機遇地圖(COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 市場趨勢
  • 主要的發展情形
  • 技術的進步
  • 供應鏈分析
  • 法規情形
  • PEST分析

第4章 組織銀行的全球市場:冠狀病毒(COVID-19)流行的影響

  • 整體影響
  • 政府的配合措施
  • COVID-19對市場的影響

第5章 組織銀行的全球市場:各產品,2017年~2030年

  • 培養基與消耗品
  • 設備
  • 凍結保存設備
  • 品管設備
  • 解凍設備
  • 其他

第6章 組織銀行的全球市場:組織各類型,2017年~2030年

  • 腦和脊髓
  • 角膜
  • 心臟瓣膜
  • 其他

第7章 組織銀行的全球市場:各地區,2017年~2030年

  • 北美
  • 美國
  • 加拿大
  • 南美
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他的南美地區
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 中東地區
  • GCC
  • 以色列
  • 其他的中東地區
  • 非洲
  • 北非
  • 中非
  • 南非

第8章 競爭情形

  • 熱圖分析
  • 企業簡介
    • AbD Serotec
    • AMS Biotechnology Limited
    • BioLife Solutions, Inc.
    • Beckman Coulter, Inc.
    • BioCision LLC
    • BioStorage Technologies, Inc.
    • Custom BioGenic Systems
    • Eppendorf AG
    • EMD Millipore Corporation
    • Fisher BioServices, Inc.
    • Genzyme Corporation
    • Hamilton Company
    • Merck KGaA
    • PHC Corporation
    • Teva Pharmaceutical Industries Ltd.

第9章 章節

  • 參考文獻
  • 調查手法
簡介目錄
Product Code: CMI2600

Tissue banks recover, process, store, and distribute tissue for transplantation. Research in the field of tissue preservation at low temperature and high clinical success of transplanted tissue led to increase in the use of stored tissue in major burn and trauma patients. Increased demand for allografts resulted in the establishment of in-house tissue banking activity at major burns centers. Tissue banking organization is a complex system and needs high technical expertise and skilled personnel for proper functioning in a dedicated facility. A tissue bank is an establishment that collects and recovers human cadaver tissue for the purposes of medical research, education and allograft transplantation. A tissue bank may also refer to a location where biomedical tissue is stored under cryogenic conditions and is generally used in a more clinical sense. Research in the field of tissue preservation at low temperature and high clinical success of transplanted tissue led to increase in the use of stored tissue in major burn and trauma patients. Increased demand of allografts resulted in the establishment of in house tissue banking activity at major burns center(s). Large numbers of skin banks were opened near major institutions handling burns patients in the U.S. There are more than fifty operational skin and tissue banks in the U.S. at present. Skin banking is a process in which tissue is removed from a donor's body, tested for suitability as a graft material, packaged and stored and finally reused as a graft.

Market Dynamics

Increasing surgical demands for allografts, demand for bone graft in hip replacements, and femoral head allografts, and increasing incidences of burn patients are the main factors for the growth of the tissue banking market. According to the WHO March 2018 report, about 180,000 deaths are caused by burns every year, majority of the cases occur in low and middle income countries. Moreover, aging population is prone to chronic diseases, such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy.

Private and public organizations are playing crucial role in fulfilling the gap between demand and supply of tissue. For instance, in 2017, MTF Biologics distributed over 550,000 tissue grafts, which was made possible through the selfless donation by 5,700 individuals. These transplantable tissues helped to heal an estimated 400,000 lives in over 50 countries.

Dearth of highly trained professionals to maintain the tissue banks is the major restraining factor for growth of the tissue banking market. For instance, according to ALZFORUM 2018 report, over the last 50 years, the number of neuropathologists on staff at the Netherlands Brain Bank dropped from 65 to about 15.

Key features of the study:

  • This report provides an in-depth analysis of the global tissue banking market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global tissue banking market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include AbD Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global tissue banking market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue banking market

Detailed Segmentation:

  • Global Tissue Banking Market, By Product:
    • Media and Consumables
    • Equipment
      • Cryopreservation Equipment
      • Quality Control Equipment
      • Thawing equipment
      • Others
  • Global Tissue Banking Market, By Tissue Type:
    • Bone
    • Brain & Spinal Cord
    • Cornea
    • Heart Valves
    • Skin
    • Others
  • Global Tissue Banking Market, By Region:
    • North America
      • By Country
    • U.S.
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Region/Country
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • AbD Serotec*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AMS Biotechnology Limited
    • BioLife Solutions, Inc.
    • Beckman Coulter, Inc.
    • BioCision LLC
    • BioStorage Technologies, Inc.
    • Custom BioGenic Systems
    • Eppendorf AG
    • EMD Millipore Corporation
    • Fisher BioServices, Inc.
    • Genzyme Corporation
    • Hamilton Company
    • Merck KGaA
    • PHC Corporation
    • Teva Pharmaceutical Industries Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Tissue Type
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technological Advancements
  • Supply Chain Analysis
  • Regulatory Landscape
  • PEST Analysis

4. Global Tissue Banking Market - Impact of Coronavirus (Covid-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the market

5. Global Tissue Banking Market, By Product, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Media and Consumables
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Equipment
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Cryopreservation Equipment
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Quality Control Equipment
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Thawing Equipment
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Tissue Banking Market, By Tissue Type, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Bone
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Brain and Spinal Cord
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Cornea
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Heart Valves
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Tissue Banking Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Tissue Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Tissue Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Tissue Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • UK
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Tissue Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Tissue Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Tissue Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • AbD Serotec
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • AMS Biotechnology Limited
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • BioLife Solutions, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Beckman Coulter, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • BioCision LLC
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • BioStorage Technologies, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Custom BioGenic Systems
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Eppendorf AG
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • EMD Millipore Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Fisher BioServices, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Genzyme Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Hamilton Company
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Merck KGaA
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • PHC Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact